|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows from Operating Activities: | |||||
| Net (loss) income | |||||
| Adjustments to reconcile net (loss) income to net cash provided by operating activities: | |||||
| Provision for credit losses on loans | |||||
| Provision for (reversal of) credit losses on unfunded loan commitments | |||||
| Noncash contribution expense to employee stock ownership plan | |||||
| Noncash director compensation expense | |||||
| Stock-based compensation expense | |||||
| Amortization of core deposit intangible | |||||
| Amortization of investment security premiums, net of accretion of discounts | |||||
| (Accretion of discounts) amortization of premiums on acquired loans, net | |||||
| Accretion of discount on subordinated notes | |||||
| Issuance costs offset to subordinated notes | |||||
| Net change in deferred loan origination costs/fees | |||||
| Write-down of other real estate owned | |||||
| Net losses on sale of investment securities | |||||
| Depreciation and amortization | |||||
| Loss on disposal of premises and equipment | |||||
| Earnings on bank-owned life insurance policies | |||||
| Earnings on bank-owned life insurance death benefits | |||||
| Net changes in: | |||||
| Net changes in interest receivable and other assets | |||||
| Net changes in interest payable and other liabilities | |||||
| Total adjustments | |||||
| Net cash provided by operating activities | |||||
| Cash Flows from Investing Activities: | |||||
| Proceeds from sale of premises and equipment | |||||
| Purchase of held-to-maturity securities | |||||
| Purchase of available-for-sale securities | |||||
| Proceeds from sale of available-for-sale securities | |||||
| Proceeds from sale of available-for-sale securities transferred from held-to-maturity | |||||
| Proceeds from paydowns/maturities of held-to-maturity securities | |||||
| Proceeds from paydowns/maturities of available-for-sale securities | |||||
| Proceeds from sale of Visa Inc. Class B restricted common stock | |||||
| (Increase) decrease in loans receivable, net | |||||
| Purchased loans | |||||
| Proceeds from sale of loan | |||||
| Purchase of bank-owned life insurance policies | |||||
| Proceeds from bank-owned life insurance policies | |||||
| Purchase of premises and equipment | |||||
| Proceeds from sale of other real estate owned | |||||
| Cash and cash equivalents acquired from American River Bankshares | |||||
| Cash paid for low income housing tax credit investment | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash Flows from Financing Activities: | |||||
| Net increase (decrease) in deposits | |||||
| Repayment of proceeds from short-term borrowings, net | |||||
| Repayment of finance lease obligations | |||||
| Repayment of subordinated debenture including execution costs | |||||
| Proceeds from issuance of subordinated notes | |||||
| Proceeds from stock options exercised | |||||
| Restricted stock surrendered for tax withholdings upon vesting | |||||
| Cash dividends paid on common stock | |||||
| Stock repurchased, including commissions | |||||
| Proceeds from stock issued under employee and director stock purchase plans | |||||
| Net cash (used in) provided by financing activities | |||||
| Net (decrease) increase in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of period | |||||
| Cash, cash equivalents and restricted cash at end of period | |||||
| Supplemental disclosure of cash flow information: | |||||
| Interest paid on deposits and borrowings | |||||
| Income taxes paid, net of refunds | |||||
| Change in net unrealized gains or losses on available-for-sale securities | |||||
| Purchase of available-for-sale security on account and unsettled | |||||
| Cumulative effect of change in accounting principle ASU 2016-13 | |||||
| Securities transferred from available-for-sale to held-to-maturity, at fair value | |||||
| Supplemental disclosure of noncash investing and financing activities: | |||||
| Change in net unrealized gains or losses on available-for-sale securities | |||||
| Amortization of net unrealized loss on AFS securities transferred to HTM | |||||
| Transfer of loan to loans held-for-sale | |||||
| Repurchase of stock not yet settled | |||||
| Stock issued in payment of director fees | |||||
| Acquisition: Fair value of assets acquired, excluding cash and cash equivalents | |||||
| Fair value of liabilities assumed | |||||
| Restricted cash | |||||
Loading...